Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will present at the Cantor Fitzgerald Healthcare Conference. Sean McCarthy, D.Phil., president and chief executive officer, will deliver a corporate overview on Wednesday, September 27, 2017, at 1:05 p.m. ET.
A live audio webcast of the presentation will be available through the Investors and News section of CytomX's website. An archived replay will be available for 90 days following the event.
About CytomX Therapeutics